Popular Articles

SC issues notices to 23 states, 3 UTs on Tata Motors' plea
The Supreme Court has issued notices to 23 states and three UTs on a petition by Tata Motors seeking quashing of the Central Sales Tax Appellate Authority"s decision asking it to pay Central Sales Tax to the tune of around Rs 14 crore on sale of bus chassis to the Andhra Pradesh government.

Telangana crisis puts India-Sri Lanka Vizag ODI in jeopardy
The political crisis in Andhra Pradesh over the Telangana issue has hit cricket as well and the BCCI is planning to shift the second India-Sri Lanka one-dayer in Visakhapatnam to another venue due to security concerns.

News of the day

Kraft to raise 7 bn pound via bonds to fund Cadbury buy
The US confectionery giant Kraft is preparing to tap the bond markets to raise as much as 7 billion pounds to help finance its 11.9 billion pound takeover of the British chocolate maker Cadbury, say media reports.
Home Business

Natco Pharma FY09 net rises 8.5% at Rs 44 cr

Hyderabad-based drug maker Natco Pharma reported an 8.5 per cent rise in its consolidated net profit at Rs 43.98 crore for the year ended March 2009, compared with Rs 40.52 crore posted in the previous year. - Lupin buys worldwide rights for nasal spray AllerNaze - Glenmark"s diabetes drug to enter phase lll trials - Emami realty arm to be listed on BSE in 3-4 months - Piramal Healthcare gets nod for appt of Nandini Piramal as ED - Sun Pharma gets USFDA nod for anti hypertensive drug - Step up vigil to stop fake Made-in-India drugs in Africa: govt Revenues were up to Rs 465 crore from Rs 364 crore in the same period, registering a growth of 28 per cent. The company stated that the growth in profit was lower on account of expenses on Phase I clinical trials of its new chemical entity with multiple oncological indications.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):